|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 126, Issue 17 3891-3904, Copyright © 1999 by Company of Biologists
JOURNAL ARTICLES |
M Sanchez, B Gottgens, AM Sinclair, M Stanley, CG Begley, S Hunter and AR Green
University of Cambridge, Department of Haematology, MRC Centre, Hills Road, Cambridge CB2 2QH, UK.
The SCL gene encodes a basic helix-loop-helix transcription factor which is expressed in early haematopoietic progenitors throughout ontogeny and is essential for the normal development of blood and blood vessels. Transgenic studies have characterised spatially distinct 5' enhancers which direct lacZ expression to subdomains of the normal SCL expression pattern, but the same elements failed to produce appropriate haematopoietic expression. We now describe an SCL 3' enhancer with unique properties. It directed lacZ expression in transgenic mice to extra-embryonic mesoderm and subsequently to both endothelial cells and to a subset of blood cells at multiple sites of embryonic haematopoiesis including the yolk sac, para-aortic splanchnopleura and AGM region. The 3' enhancer also targeted expression to haematopoietic progenitors in both foetal liver and adult bone marrow. Purified lacZ(+ )cells were highly enriched for clonogenic myeloid and erythroid progenitors as well as day-12 spleen colony forming units (CFU-S). Within the total gated population from bone marrow, 95% of the myeloid and 90% of the erythroid colony-forming cells were contained in the lacZ(+) fraction, as were 98% of the CFU-S. Activation of the enhancer did not require SCL protein. On the contrary, transgene expression in yolk sacs was markedly increased in an SCL-/- background, suggesting that SCL is subject to negative autoregulation. Alternatively the SCL-/- environment may alter differentiation of extra-embryonic mesoderm and result in an increased number of cells capable of expressing high levels of the transgene. Our data represents the first description of an enhancer that integrates information necessary for expression in developing endothelium and early haematopoietic progenitors at distinct times and sites throughout ontogeny. This enhancer provides a potent tool for the manipulation of haematopoiesis and vasculogenesis in vivo.
This article has been cited by other articles:
![]() |
J.-R. Landry, N. Bonadies, S. Kinston, K. Knezevic, N. K. Wilson, S. H. Oram, M. Janes, S. Piltz, M. Hammett, J. Carter, et al. Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors Blood, June 4, 2009; 113(23): 5783 - 5792. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Pimanda, W. Y. I. Chan, N. K. Wilson, A. M. Smith, S. Kinston, K. Knezevic, M. E. Janes, J.-R. Landry, A. Kolb-Kokocinski, J. Frampton, et al. Endoglin expression in blood and endothelium is differentially regulated by modular assembly of the Ets/Gata hemangioblast code Blood, December 1, 2008; 112(12): 4512 - 4522. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Smith, M.-J. Sanchez, G. A. Follows, S. Kinston, I. J. Donaldson, A. R. Green, and B. Gottgens A novel mode of enhancer evolution: The Tal1 stem cell enhancer recruited a MIR element to specifically boost its activity Genome Res., September 1, 2008; 18(9): 1422 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-R. Landry, S. Kinston, K. Knezevic, M. F.T.R. de Bruijn, N. Wilson, W. T. Nottingham, M. Peitz, F. Edenhofer, J. E. Pimanda, K. Ottersbach, et al. Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver Blood, March 15, 2008; 111(6): 3005 - 3014. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Pimanda, K. Ottersbach, K. Knezevic, S. Kinston, W. Y. I. Chan, N. K. Wilson, J.-R. Landry, A. D. Wood, A. Kolb-Kokocinski, A. R. Green, et al. Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development PNAS, November 6, 2007; 104(45): 17692 - 17697. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ogilvy, R. Ferreira, S. G. Piltz, J. M. Bowen, B. Gottgens, and A. R. Green The SCL +40 Enhancer Targets the Midbrain Together with Primitive and Definitive Hematopoiesis and Is Regulated by SCL and GATA Proteins Mol. Cell. Biol., October 15, 2007; 27(20): 7206 - 7219. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Follows, M. E. Janes, L. Vallier, A. R. Green, and B. Gottgens Real-time PCR mapping of DNaseI-hypersensitive sites using a novel ligation-mediated amplification technique Nucleic Acids Res., April 3, 2007; 35(8): e56 - e56. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. I. Chan, G. A. Follows, G. Lacaud, J. E. Pimanda, J.-R. Landry, S. Kinston, K. Knezevic, S. Piltz, I. J. Donaldson, L. Gambardella, et al. The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype Blood, March 1, 2007; 109(5): 1908 - 1916. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Pimanda, I. J. Donaldson, M. F. T. R. de Bruijn, S. Kinston, K. Knezevic, L. Huckle, S. Piltz, J.-R. Landry, A. R. Green, D. Tannahill, et al. The SCL transcriptional network and BMP signaling pathway interact to regulate RUNX1 activity PNAS, January 16, 2007; 104(3): 840 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Follows, P. Dhami, B. Gottgens, A. W. Bruce, P. J. Campbell, S. C. Dillon, A. M. Smith, C. Koch, I. J. Donaldson, M. A. Scott, et al. Identifying gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sites Genome Res., October 1, 2006; 16(10): 1310 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bockamp, C. Antunes, M. Maringer, R. Heck, K. Presser, S. Beilke, S. Ohngemach, R. Alt, M. Cross, R. Sprengel, et al. Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cells Blood, September 1, 2006; 108(5): 1533 - 1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Pimanda, W.Y. I. Chan, I. J. Donaldson, M. Bowen, A. R. Green, and B. Gottgens Endoglin expression in the endothelium is regulated by Fli-1, Erg, and Elf-1 acting on the promoter and a -8-kb enhancer Blood, June 15, 2006; 107(12): 4737 - 4745. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Pimanda, L. Silberstein, M. Dominici, B. Dekel, M. Bowen, S. Oldham, A. Kallianpur, S. J. Brandt, D. Tannahill, B. Gottgens, et al. Transcriptional Link between Blood and Bone: the Stem Cell Leukemia Gene and Its +19 Stem Cell Enhancer Are Active in Bone Cells. Mol. Cell. Biol., April 1, 2006; 26(7): 2615 - 2625. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-R. Landry, S. Kinston, K. Knezevic, I. J. Donaldson, A. R. Green, and B. Gottgens Fli1, Elf1, and Ets1 regulate the proximal promoter of the LMO2 gene in endothelial cells Blood, October 15, 2005; 106(8): 2680 - 2687. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rosenbauer, S. Koschmieder, U. Steidl, and D. G. Tenen Effect of transcription-factor concentrations on leukemic stem cells Blood, September 1, 2005; 106(5): 1519 - 1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Delabesse, S. Ogilvy, M. A. Chapman, S. G. Piltz, B. Gottgens, and A. R. Green Transcriptional Regulation of the SCL Locus: Identification of an Enhancer That Targets the Primitive Erythroid Lineage In Vivo Mol. Cell. Biol., June 15, 2005; 25(12): 5215 - 5225. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Gothert, S. E. Gustin, M. A. Hall, A. R. Green, B. Gottgens, D. J. Izon, and C. G. Begley In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis Blood, April 1, 2005; 105(7): 2724 - 2732. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Donaldson, M. Chapman, S. Kinston, J. R. Landry, K. Knezevic, S. Piltz, N. Buckley, A. R. Green, and B. Gottgens Genome-wide identification of cis-regulatory sequences controlling blood and endothelial development Hum. Mol. Genet., March 1, 2005; 14(5): 595 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eguchi, M. Eguchi-Ishimae, A. Green, T. Enver, and M. Greaves Directing oncogenic fusion genes into stem cells via an SCL enhancer PNAS, January 25, 2005; 102(4): 1133 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koschmieder, B. Gottgens, P. Zhang, J. Iwasaki-Arai, K. Akashi, J. L. Kutok, T. Dayaram, K. Geary, A. R. Green, D. G. Tenen, et al. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis Blood, January 1, 2005; 105(1): 324 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Gothert, S. E. Gustin, J. A. M. van Eekelen, U. Schmidt, M. A. Hall, S. M. Jane, A. R. Green, B. Gottgens, D. J. Izon, and C. G. Begley Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium Blood, September 15, 2004; 104(6): 1769 - 1777. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xue, X. Chen, Y. Chang, and J. J. Bieker Regulatory elements of the EKLF gene that direct erythroid cell-specific expression during mammalian development Blood, June 1, 2004; 103(11): 4078 - 4083. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gottgens, C. Broccardo, M.-J. Sanchez, S. Deveaux, G. Murphy, J. R. Gothert, E. Kotsopoulou, S. Kinston, L. Delaney, S. Piltz, et al. The scl +18/19 Stem Cell Enhancer Is Not Required for Hematopoiesis: Identification of a 5' Bifunctional Hematopoietic-Endothelial Enhancer Bound by Fli-1 and Elf-1 Mol. Cell. Biol., March 1, 2004; 24(5): 1870 - 1883. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Chapman, I. J. Donaldson, J. Gilbert, D. Grafham, J. Rogers, A. R. Green, and B. Gottgens Analysis of Multiple Genomic Sequence Alignments: A Web Resource, Online Tools, and Lessons Learned From Analysis of Mammalian SCL Loci Genome Res., February 1, 2004; 14(2): 313 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Cairns, E. Moroni, E. Levantini, A. Giorgetti, F. G. Klinger, S. Ronzoni, L. Tatangelo, C. Tiveron, M. De Felici, S. Dolci, et al. Kit regulatory elements required for expression in developing hematopoietic and germ cell lineages Blood, December 1, 2003; 102(12): 3954 - 3962. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Huettner, S. Koschmieder, H. Iwasaki, J. Iwasaki-Arai, H. S. Radomska, K. Akashi, and D. G. Tenen Inducible expression of BCR/ABL using human CD34 regulatory elements results in a megakaryocytic myeloproliferative syndrome Blood, November 1, 2003; 102(9): 3363 - 3370. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Murphy, B. Gottgens, A. Vegiopoulos, M.-J. Sanchez, A. D. Leavitt, S. P. Watson, A. R. Green, and J. Frampton Manipulation of Mouse Hematopoietic Progenitors by Specific Retroviral Infection J. Biol. Chem., October 31, 2003; 278(44): 43556 - 43563. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moser, O. Binder, Y. Wu, J. Aitsebaomo, R. Ren, C. Bode, V. L. Bautch, F. L. Conlon, and C. Patterson BMPER, a Novel Endothelial Cell Precursor-Derived Protein, Antagonizes Bone Morphogenetic Protein Signaling and Endothelial Cell Differentiation Mol. Cell. Biol., August 15, 2003; 23(16): 5664 - 5679. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Z. Chen, M. Li, D. de Graaf, S. Monti, B. Gottgens, M.-J. Sanchez, E. S. Lander, T. R. Golub, A. R. Green, and H. F. Lodish Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells PNAS, November 26, 2002; 99(24): 15468 - 15473. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Oberlin, M. Tavian, I. Blazsek, and B. Peault Blood-forming potential of vascular endothelium in the human embryo Development, September 1, 2002; 129(17): 4147 - 4157. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Sinclair, A. J. Bench, A. J. C. Bloor, J. Li, B. Gottgens, M. L. Stanley, J. Miller, S. Piltz, S. Hunter, E. P. Nacheva, et al. Rescue of the lethal scl-/- phenotype by the human SCL locus Blood, May 13, 2002; 99(11): 3931 - 3938. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gottgens, L. M. Barton, M. A. Chapman, A. M. Sinclair, B. Knudsen, D. Grafham, J. G.R. Gilbert, J. Rogers, D. R. Bentley, and A. R. Green Transcriptional Regulation of the Stem Cell Leukemia Gene (SCL) --- Comparative Analysis of Five Vertebrate SCL Loci Genome Res., May 1, 2002; 12(5): 749 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. J. Oostendorp, K. N. Harvey, N. Kusadasi, M. F. T. R. de Bruijn, C. Saris, R. E. Ploemacher, A. L. Medvinsky, and E. A. Dzierzak Stromal cell lines from mouse aorta-gonads-mesonephros subregions are potent supporters of hematopoietic stem cell activity Blood, February 15, 2002; 99(4): 1183 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Sanchez, E.-O. Bockamp, J. Miller, L. Gambardella, and A. R. Green Selective rescue of early haematopoietic progenitors in Scl-/- mice by expressing Scl under the control of a stem cell enhancer Development, December 1, 2001; 128(23): 4815 - 4827. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Rothenberg Mapping of complex regulatory elements by pufferfish/zebrafish transgenesis PNAS, June 5, 2001; 98(12): 6540 - 6542. [Full Text] [PDF] |
||||
![]() |
B. Göttgens, J. G.R. Gilbert, L. M. Barton, D. Grafham, J. Rogers, D. R. Bentley, and A. R. Green Long-Range Comparison of Human and Mouse SCL Loci: Localized Regions of Sensitivity to Restriction Endonucleases Correspond Precisely with Peaks of Conserved Noncoding Sequences Genome Res., January 1, 2001; 11(1): 87 - 97. [Abstract] [Full Text] |
||||
![]() |
L. M. Barton, B. Gottgens, M. Gering, J. G. R. Gilbert, D. Grafham, J. Rogers, D. Bentley, R. Patient, and A. R. Green From the Cover: Regulation of the stem cell leukemia (SCL) gene: A tale of two fishes PNAS, June 5, 2001; 98(12): 6747 - 6752. [Abstract] [Full Text] [PDF] |
||||